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Abstract Notch signaling regulates squamous cell proliferation and differentiation and is
frequently disrupted in squamous cell carcinomas, in which Notch is tumor suppressive. Here, we
show that conditional activation of Notch in squamous cells activates a context-specific gene
expression program through lineage-specific regulatory elements. Among direct Notch target
genes are multiple DNA damage response genes, including IER5, which we show is required for
Notch-induced differentiation of squamous carcinoma cells and TERT-immortalized keratinocytes.
IER5 is epistatic to PPP2R2A, a gene that encodes the PP2A B55a subunit, which we show interacts
with IER5 in cells and in purified systems. Thus, Notch and DNA-damage response pathways
converge in squamous cells on common genes that promote differentiation, which may serve to
eliminate damaged cells from the proliferative pool. We further propose that crosstalk involving
Notch and PP2A enables tuning and integration of Notch signaling with other pathways that
regulate squamous differentiation.
Introduction
Notch receptors participate in a conserved signaling pathway in which successive ligand-mediated
proteolytic cleavages by ADAM10 and g-secretase permit intracellular Notch (ICN) to translocate to
the nucleus and form a Notch transcription complex (NTC) with the DNA-binding factor RBPJ and
co-activators of the Mastermind-like (MAML) family (for review, see Bray, 2016). Outcomes of Notch
activation are dose and cell-context-dependent, in part because most Notch response elements lie
within lineage-specific enhancers (Castel et al., 2013; Ryan et al., 2017; Skalska et al., 2015;
Wang et al., 2014). As a result, Notch-dependent transcriptional programs vary widely across cell
types.
The context-dependency of outcomes produced by Notch signaling is reflected in the varied pat-
terns of Notch mutations that are found in different cancers (for review, see Aster et al., 2017). In
some cancers oncogenic gain-of-function Notch mutations predominate, but in human cutaneous
squamous cell carcinoma (SCC) (South et al., 2014; Wang et al., 2011) loss-of-function mutations
are common, early driver events, observations presaged by work showing that loss of Notch function
promotes skin cancer development in mouse models (Nicolas et al., 2003; Proweller et al., 2006).
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The mechanism underlying the tumor suppressive effect of Notch appears to involve its ability to
promote squamous differentiation at the expense of self-renewal, a function that is operative in
other squamous epithelia (Alcolea et al., 2014), where Notch also has tumor suppressive activities
(Agrawal et al., 2011; Agrawal et al., 2012; Loganathan et al., 2020). In line with this idea, condi-
tional ablation of Notch1 in postnatal mice results in epidermal hyperplasia and expansion of prolif-
erating basal-like cells (Nicolas et al., 2003; Rangarajan et al., 2001). Moreover, murine and human
b-papilloma viruses express E6 proteins that target MAML1 and inhibit Notch function
(Meyers et al., 2017; Tan et al., 2012), thereby causing epidermal hyperplasia and delayed differen-
tiation of infected keratinocytes. Conversely, constitutively active forms of Notch enhance keratino-
cyte differentiation in vitro and in vivo (Nickoloff et al., 2002; Rangarajan et al., 2001;
Uyttendaele et al., 2004).
While these studies delineate a pro-differentiation, tumor suppressive role for Notch in squamous
cells, little is known about the Notch target genes that confer this phenotype. Work to date has
focused on candidate genes chosen for their known activities in keratinocytes or their roles as Notch
target genes in other cell types. These include CDKN1A/p21 (Rangarajan et al., 2001), which has
been linked to cell cycle arrest and differentiation (Missero et al., 1996); HES1, which represses
basal fate/self-renewal (Blanpain et al., 2006); and IRF6, expression of which positively correlates
with Notch activation in keratinocytes (Restivo et al., 2011). However, dose- and time-controlled
genome-wide studies to determine the immediate, direct effects of Notch activation in squamous-
lineage cells have yet to be performed.
To this end, we developed and validated 2D and 3D culture models of malignant and non-trans-
formed human squamous epithelial cells in which tightly regulated Notch activation produces growth
arrest and squamous differentiation. We find that immediate, direct Notch target genes are largely
keratinocyte-specific and are associated with lineage-specific NTC-binding enhancers enriched for
the motifs of transcription factors linked to regulation of keratinocyte differentiation, particularly
AP1. Among these targets are multiple genes previously shown to be upregulated by DNA damage
and cell stress, including IER5, a member of the AP1-regulated immediate early response gene fam-
ily (Williams et al., 1999). Here, we show that IER5 is required for Notch-induced differentiation of
human SCC cells and TERT-immortalized human keratinocytes, and that this requirement is abol-
ished by knockout of the B55a regulatory subunit of PP2A, to which IER5 directly binds. Our studies
provide the first genome-wide view of the effects of Notch on gene expression in cutaneous squa-
mous carcinoma cells, highlight previously unrecognized crosstalk between Notch and DNA
response genes, and point to the existence of a Notch-IER5-PP2A signaling axis that coordinates
keratinocyte differentiation.
Establishment of a conditional Notch-on SCC model
Determination of the immediate, direct effects of Notch in a model system requires tightly timed,
switch-like Notch activation. This is difficult to achieve with ligands because simple addition of solu-
ble Notch ligands does not induce signaling (Sun and Artavanis-Tsakonas, 1997). Methods of trig-
gering Notch activation include plating of cells on immobilized ligands (Varnum-Finney et al.,
2000); treatment with EDTA, which renders Notch susceptible to activating cleavages by chelating
Ca2+ and thereby destabilizing the Notch negative regulatory region (Rand et al., 2000); and g-sec-
retase inhibitor (GSI) washout, which reliably delivers a pulse of ICN in 15–30 min to the nuclei of
cells expressing mutated or truncated forms of membrane-tethered Notch (Petrovic et al., 2019;
Ryan et al., 2017; Wang et al., 2014; Weng et al., 2006). Plating of adherent cells on substrate
coated with immobilized ligand is confounded by the need to first produce cell suspensions with
trypsin and/or EDTA, which activates Notch in cells expressing Notch receptors. EDTA treatment
also suffers from several limitations: (i) Notch activation is confined to a period of several minutes
immediately following EDTA addition and is therefore limited in degree and duration, possibly
because chelation of Zn2+ also rapidly inactivates ADAM metalloproteases and (ii) off-target effects
of EDTA, including on surface proteins that mediate cell adhesion. GSI washout is open to criticism
because g-secretase has numerous substrates in addition to Notch receptors, raising questions about
specificity. However, major phenotypes induced by treatment of flies (Micchelli et al., 2003), mice
(van Es et al., 2005), and humans (Aster and Blacklow, 2012) with GSI are all related to Notch inhi-
bition, strongly suggesting that Notch is the dominant GSI substrate at the organismal level. In line
with these observations, in prior work we have noted that cells lacking ongoing Notch signaling
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show little or no change in phenotype when treated with GSI, and we therefore selected GSI wash-
out to produce timed activation of Notch in cells of squamous lineage.
To create a squamous cell model in which GSI washout activates NOTCH1 (Figure 1A), we first
engineered a cDNA encoding a mutated truncated form of NOTCH1, DEGF-L1596H, that cannot
respond to ligand and that has a point substitution in its negative regulatory region that produces
ligand-independent, g-secretase-dependent Notch activation (Gordon et al., 2009; Malecki et al.,
2006). Notably, when expressed from retroviruses NOTCH1 alleles bearing negative regulatory
region mutations like L1596H generate Notch signals that are sufficient to produce physiologic
effects in hematopoietic stem cells (induction of T cell differentiation) without causing pathophysio-
logic effects (induction of T cell acute lymphoblastic leukemia) (Chiang et al., 2008). Because Notch
transcription complexes appear to largely act through ‘poised’ enhancers primed by lineage-specific
‘pioneer’ transcription factors (Falo-Sanjuan et al., 2019), we reasoned that squamous cell carci-
noma lines with loss-of-function Notch mutations and little/no ongoing Notch signaling would be an
ideal context in which to identify direct downstream targets of Notch. We therefore transduced
DEGF-L1596H into two human SCC cell lines, IC8 and SCCT2, that have biallelic inactivating muta-
tions in NOTCH1 and TP53 (Inman et al., 2018), lesions that were confirmed by resequencing on a
clinical-grade targeted exome NGS platform (summarized in Tables 1 and 2).
In pilot studies, we observed that the growth of IC8 and SCCT2 cells transduced with empty virus
was unaffected by the presence or absence of GSI, whereas the growth of lines transduced with
DEGF-L1596H was reduced by GSI washout (Figure 1—figure supplement 1A, B). GSI washout was
accompanied by rapid activation of NOTCH1 (ICN1) followed by upregulation of markers of differen-
tiation, such as involucrin (Figure 1—figure supplement 1C, D). Of interest, ICN1 levels reproduc-
ibly peaked at around 4 hr and then declined, suggesting that sustained NOTCH1 activation and
accompanying changes in cell state led to induction of feedback loops that negatively regulate
ICN1. We also observed that IC8-DEGF-L1596H cells formed ‘skin-like’ epithelia when seeded onto
organotypic 3D cultures, whereas SCCT2-DEGF-L1596H cells did not (data not shown); therefore,
additional studies focused on IC8 cells and derivatives thereof.
To further characterize and validate our system, we performed single-cell cloning of IC8 DEGF-
L1596H cells and observed that differentiation following GSI washout correlated with ICN1 accumu-
lation (Figure 1—figure supplement 2A and B). The subclone SC2, which showed moderate accu-
mulation of ICN1 and sharply reduced growth following GSI washout, was selected for further study.
The ability of SC2 cells to form a multilayered epithelium in the Notch-on, growth suppressive state
appears to stem from an unexpected property that emerged in 3D cultures, namely the self-organi-
zation of these cells into a proliferating, ICN1-low basal layer in contact with matrix and a non-prolif-
erating, ICN1-high suprabasal layer (Figure 1—figure supplement 2C). The self-organization of
Notch-on SC2 cells grown on collagen rafts into ICN1-low basal proliferating cells and ICN1-high
suprabasal non-proliferating cells suggested that contact of SC2 cells with collagen reduces ICN1
levels. To test this idea, we plated SC2 cells on plastic or collagen, washed out GSI, and compared
ICN1 levels by western blotting. As shown in Figure 1—figure supplement 2D, culture of SC2 cells
on collagen sharply reduced ICN1 levels, whereas the level of total NOTCH1 polypeptides was
unchanged or slightly increased in cells grown on collagen. These observations point to the exis-
tence of one or more matrix-dependent effects that decrease ICN1 levels and which may serve to
reinforce the ‘Notch-low’ status of basal keratinocytes.
We also noted that the growth arrest induced by GSI washout in SC2 cells was blocked by domi-
nant-negative MAML1 (DN-MAML), a specific inhibitor of Notch-dependent transcription
(Figure 1B; Nam et al., 2007; Weng et al., 2003), confirming that the growth inhibitory effects of
GSI washout are mediated through Notch activation. Growth arrest occurred several days after
Notch activation (compare Figure 1B and C) and was accompanied by upregulation of multiple
markers of squamous differentiation, such as involucrin, keratin1, and plakophilin1, in 2D
(Figure 1C–E) and in 3D cultures (Figure 1F). In addition, we also noted that staining for keratin14,
a prototypic marker of proliferating basal keratinocytes (Fuchs, 1995), became more sharply local-
ized to basal cells in Notch-on SC2 cells (Figure 1F).
Although Notch activation in IC8 and SC2 cells clearly induced expression of squamous differenti-
ation markers, the distribution of these markers in 3D cultures failed to precisely mimic that of nor-
mal epidermis, as staining for involucrin and plakophilin-1 was seen in proliferating keratin14-
positive basal cells. The observed expression of spinous markers in ICN1-low proliferating basal cells
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Figure 1. Notch activation induces growth arrest and differentiation of squamous carcinoma cells. (A) Strategy used to activate Notch in a tightly
regulated fashion. (B) Notch-induced suppression of SC2 cell growth in standard cultures is abrogated by DN-MAML, a specific inhibitor of canonical
Notch signaling. SC2 cells were transduced with empty MigRI virus (EV) or with MigRI virus encoding DN-MAML. Cell numbers at various times post-
GSI washout (DMSO vehicle alone) or sham GSI-washout (GSI) were assessed using Cell Titer-Blue on biological replicates performed in quadruplicate.
Figure 1 continued on next page
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may be explained by differing Notch dose requirements for growth arrest (relatively high) versus
induction of spinous differentiation (relatively low). To further compare and contrast the effects of
Notch activation in SC2 cells with normal keratinocyte differentiation, we performed staining for a
series of additional markers (Figure 1—figure supplement 3). Similar to normal keratinocyte differ-
entiation, Notch activation was associated with increased staining for BCL6, particularly in suprabasal
SC2 cells. By contrast, p63 staining, which is normally confined to basal keratinocytes, was seen in
suprabasal as well as basal SC2 cells, and keratin5 staining was observed throughout SC2 cell rafts,
in contradistinction to keratin14 staining (Figure 1F). Notch activation also failed to induce staining
for markers of terminal differentiation such as filaggrin (Figure 1—figure supplement 3) and loricrin
(not shown). Thus, Notch activation in SC2 cells induces genes associated with spinous differentia-
tion but is insufficient to down-regulate certain genes associated with basal cell fate, such as p63
and keratin5, or to push SC2 cells to terminally differentiate.
Identification of a squamous cell-specific Notch-induced program of
gene expression
To determine early and delayed effects of Notch on gene expression, we performed RNA-seq on
SC2 cells in 2D cultures in the Notch-off state and following Notch activation. Because g-secretase
has numerous substrates, as a control we performed RNA-seq on parental, non-transduced IC8 cells
in the presence of GSI and following GSI washout, which revealed no significant GSI-dependent
changes in gene expression in the absence of a Notch transgene (Figure 2—figure supplement 1).
By contrast, Notch activation in SC2 cells produced significant changes in gene expression by 4 hr
that became more pronounced by 24 hr and 72 hr (Figure 2A, see Supplementary files 1–3 for dif-
ferentially expressed genes). Gene ontology (GO) analysis revealed enrichment among upregulated
genes for those that are associated with keratinocyte differentiation and biology
(Supplementary files 4 and 5, summarized in Figure 2B). Among the rapidly upregulated genes
(genes that increase in expression by 4 hr) were several reported targets of Notch in keratinocytes
(e.g, RHOV [Pomrey and Radtke, 2010], HES1 [Blanpain et al., 2006], and IRF6 [Restivo et al.,
2011]), but most genes in this class were novel for keratinocytes and included: (1) direct targets of
Notch in other lineages (e.g. NRARP, HES4, and HES5); (2) genes linked to keratinocyte differentia-
tion (e.g. RIPK4 [Kwa et al., 2014], recently reported to be upregulated following treatment of kera-
tinocytes with EDTA [Loganathan et al., 2020], and SMAD3 [Meyers et al., 2017]); (3) genes
associated with DNA damage responses in keratinocytes and other cell types (e.g. GADD45A,
CXCL8, IL1B, ID3, CYR61, BTG2, IER3, and IER5 [Kis et al., 2006; Kumar et al., 1998; Maeda et al.,
2002; Rouault et al., 1996; Sesto et al., 2002; Simbulan-Rosenthal et al., 2006]); and (4) genes
associated with growth arrest of keratinocytes and other cell types (e.g. HES1 [Blanpain et al.,
2006], GADD45A [Maeda et al., 2002], and BTG2 [Rouault et al., 1996]).
To confirm that these changes in gene expression are general features of Notch activation in IC8-
DEGF-L1596H cells and to determine the kinetics of response, we performed RT-PCR analyses on a
number of known and novel targets in pooled IC8-DEGF-L1596H transductants. This confirmed the
Figure 1 continued
Error bars represent standard deviations. Timepoints with significantly different cell growth between Notch-on cells (DMSO, empty vector) and Notch-
off cells (GSI, empty vector; DMSO, DN-MAML1; and GSI, DN-MAML1) are denoted with *** (p<0.005) or **** (p<0.0005) (two-tailed student t test). (C)
Western blot showing the kinetics of activated intracellular NOTCH1 (ICN1) generation and increases in involucrin (IVL) following GSI washout in SC2
cells in standard cultures. (D) Notch-induced differentiation of SC2 cells is abrogated by DN-MAML. Transcripts for involucrin (IVL) and keratin1 (KRT1)
were measured in the presence of GSI and 3 days after GSI washout in SC2 cells transduced with empty virus or with DN-MAML. Transcript abundance
in biological replicates performed in triplicate was measured by RT-PCR and normalized against GAPDH. Error bars represent standard deviations of
the mean. **, p<0.005; *, p<0.05; two-tailed student t-test. (E) Indirect immunofluorescence microscopy showing staining for involucrin (IVL, green) and
plakophilin-1 (PKP1, red) in SC2 cells at time 0 and 6 and 8 days after GSI washout. Nuclei in each image were counterstained with DAPI. (F)
Immunohistochemical staining of SC2 cells grown in skin raft cultures for 14 days in the presence and absence of GSI.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Notch activation induces differentiation and growth arrest of the squamous carcinoma cell lines IC8 and SCCT2.
Figure supplement 2. Characterization of clones derived from single IC8 cells transduced with DEGF-L1596H.
Figure supplement 3. Immunohistochemical assessment of p63, BCL6, keratin5 (KRT5), and filaggrin (FLGR) protein levels in S2 cells grown in the
Notch-off (GSI) or Notch-on (WO) states in 3D rafts.
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Table 1. Sequence variants, IC8* and SCCT2** squamous cell carcinoma cell lines.
Gene Variant Variant allele frequency
IC8 cell
CASP8 c.971T > C(p.M324T) 66% of 411 reads
FBXW7 c.1633T > C(p.Y545H) 33% of 195 reads
KMT2D c.7412G > A(p.R2471Q) 42% of 255 reads
MGA c.5599G > A(p.V1867I) 39% of 710 reads
MTOR c.4828G > A(p.E1610K) 56% of 280 reads
NOTCH1 c.5059C > T (p.Q1687*) 100% of 412 reads
PAXIP1 c.2023C > T(p.H675Y) 17% of 384 reads
PMS1 c.566_567delTCinsAT(p.V189D) 36% of 108 reads
RIF1 c.658G > A(p.E220K) 62% of 251 reads
ROS1 c.1144T > G(p.Y382D) 87% of 169 reads
ROS1 c.1164+2_1164+8delTTAGTCC () 19% of 191 reads
SDHA c.1627T > C(p.Y543H) 56% of 668 reads
SF3B1 c.2549T > C(p.I850T) 31% of 246 reads
TERT CC242-243TT promoter mutation 50% of 26 reads
TP53 c.451C > T(p.P151S) 100% of 366 reads
WHSC1 c.2185C > T(p.R729C) 66% of 410 reads
WWTR1 c.551T > G (p.V184G) 64% of 256 reads
ZNF217 c.2590C > T(p.L864F) 39% of 835 reads
ZNF217 c.1162delC(p.H388Tfs*77) 55% of 822 reads
SCCT2 Cell
ALK c.2854G > A (p.G952R) 50% of 441 reads
ASXL1 c.3959C > T (p.A1320V) 31% of 930 reads
BRD3 c.533C > T (p.S178F) 49% of 281 reads
BRD4 c.3915_3917dupTGC (p.A1306dup) 45% of 170 reads
CDH4 c.1801C > T (p.L601F) 30% of 447 reads
CDKN2A c.*151–1G > A () 100% of 172 reads
CDKN2A c.212A > T (p.N71I) 100% of 184 reads
CREBBP c.5842C > T (p.P1948S) 74% of 77 reads
CREBBP c.2116G > A (p.G706R) 45% of 172 reads
DDB1 c.327+6G > A () 47% of 451 reads
DICER1 c.775C > T (p.P259S) 42% of 301 reads
DOCK8 c.185T > A (p.V62E) 100% of 597 reads
EGFR c.1955G > A (p.G652E) 48% of 518 reads
EGFR c.298C > T (p.P100S) 49% of 595 reads
ERCC2 c.886A > T (p.S296C) 48% of 165 reads
ERCC5 c.264+1G > A () 50% of 442 reads
ETV4 c.1298C > G (p.P433R) 45% of 302 reads
FANCF c.494C > T (p.T165I) 50% of 644 reads
FANCL c.155+1G > A () 51% of 220 reads
FAT1 c.9076–1G > A () 49% of 367 reads
FH c.681G > T (p.Q227H) 4% of 756 reads
FLT4 c.2224G > A (p.D742N) 49% of 346 reads
GALNT12 c.1035+5G > A () 52% of 523 reads
GLI2 c.1859C > A (p.T620K) 45% of 351 reads
Table 1 continued on next page
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Table 1 continued
Gene Variant Variant allele frequency
HNF1A c.1640C > T (p.T547I) 54% of 392 reads
JAZF1 c.477C > T (p.I159I) 47% of 606 reads
JAZF1 c.328C > T (p.P110S) 44% of 211 reads
KMT2D c.10355+1G > A () 49% of 622 reads
LIG4 c.1271_1275delAAAGA (p.K424Rfs*20) 40% of 659 reads
MAP2K1 c.568+1G > A () 53% of 239 reads
MED12 c.2080G > A (p.E694K) 100% of 269 reads
MYB c.1461+5G > A () 41% of 430 reads
NF1 c.2608G > A (p.V870I) 50% of 615 reads
NF2 c.813T > G (p.F271L) 48% of 168 reads
NOTCH1 c.1226G > T (p.C409F) 44% of 519 reads
NOTCH1 c.1406A > G (p.D469G) 50% of 912 reads
NOTCH1 c.1245G > T (p.E415D) 42% of 495 reads
NOTCH2 c.5252G > A (p.G1751D) 44% of 459 reads
NOTCH2 c.1298G > A (p.C433Y) 50% of 484 reads
NOTCH2 c.1108+1G > A () 53% of 305 reads
NSD1 c.7669G > A (p.G2557R) 49% of 743 reads
PDGFRB c.2586+2T > A () 43% of 380 reads
PHOX2B c.181A > T (p.T61S) 52% of 222 reads
POLQ c.6565G > A (p.A2189T) 27% of 462 reads
POLQ c.1634G > A (p.S545N) 33% of 667 reads
PPARG c.819+6T > C () 100% of 134 reads
PRKDC c.6436G > A (p.A2146T) 42% of 471 reads
RAD51C c.996G > A (p.Q332Q) 45% of 302 reads
RHEB c.443C > T (p.S148F) 46% of 120 reads
ROS1 c.6871C > T (p.P2291S) 45% of 605 reads
ROS1 c.3342A > T (p.Q1114H) 48% of 274 reads
ROS1 c.137A > T (p.D46V) 42% of 215 reads
RPTOR c.2992G > A (p.V998I) 48% of 352 reads
RUNX1T1 c.1039G > A (p.D347N) 45% of 715 reads
SDHA c.1151C > T (p.S384L) 53% of 446 reads
SLC34A2 c.1700T > A (p.I567N) 50% of 460 reads
SMARCA4 c.3947T > G (p.F1316C) 55% of 431 reads
SMARCE1 c.395C > T (p.A132V) 51% of 587 reads
STAT3 c.1852G > A (p.G618S) 47% of 527 reads
TDG c.166+4G > A () 48% of 329 reads
TP53 c.375+1G > T 47% of 173 reads
TP53 c.832_833delCCinsTT
(p.P278F)
46% of 418 reads
UIMC1 c.971T > C (p.V324A) 48% of 745 reads
XPC c.571C > T (p.R191W) 100% of 219 reads
*Based on analysis of 16,131,317 unique, high-quality sequencing reads (mean, 406 reads per targeted exon, with
98% of exons having more than 30 reads).
†Based on analysis of 20,972,158 unique, high-quality sequencing reads (mean, 413 reads per targeted exon, with
99% of exons having more than 30 reads).
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Notch responsiveness of all genes tested, and also revealed variation in the kinetics of response,
even among ‘canonical’ Notch target genes. For example, HES1 showed fast induction followed by
rapid down-regulation, consistent with autoinhibition (Hirata et al., 2002), whereas HES4, HES5,
and NRARP (a feedback inhibitor of NTC function [Jarrett et al., 2019]) showed more sustained
increases in expression (Figure 2C). Genes encoding non-structural proteins known to be linked to
squamous differentiation also were ‘early’ responders (Figure 2D), as were genes linked to DNA
damage/cell stress response (Figure 2E). In the case of the latter novel targets, we confirmed that
protein levels also rose in a Notch-dependent fashion (Figure 2F). By contrast, increased expression
of genes encoding structural proteins associated with keratinocyte differentiation (e.g. IVL, KRT1,
KRT13) was delayed, only emerging at 24–72 hr (Supplementary files 1–3). These findings suggest
that Notch activation induces the expression of a core group of early direct target genes, setting in
motion downstream events that lead to differentiation.
Notch activation also down-regulated a smaller set of genes (Figure 2A, summarized in
Supplementary files 1–3), possibly via induction of transcriptional repressors of the Hes family.
These include multiple genes expressed by basal epidermal stem cells, including genes encoding
the Notch ligand DLL1 (Lowell et al., 2000); b1-integrin (Jones and Watt, 1993); LRIG1
(Jensen and Watt, 2006), a negative regulator of epidermal growth factor receptor signaling; and
multiple WNT ligands (WNT7A, 7B, 9A, 10A, and 11), of interest because WNT signaling contributes
to maintenance of epidermal stem cells (Lim et al., 2013).
To determine the overlap of Notch target genes in squamous cells with other cell lineages, we
compared the list of Notch-responsive genes in SC2 cells with three other cell types in which GSI
washout has been used to identify genes that are rapidly upregulated by Notch: triple-negative
breast cancer cells (Petrovic et al., 2019); mantle cell lymphoma cells (Ryan et al., 2017); and T-cell
acute lymphoblastic leukemia (T-ALL) cells. Using fairly stringent cutoffs for Notch-responsiveness
(FDR < 0.05, log2 change >1; summarized in Supplementary file 6), we failed to identify any genes
that were co-regulated by Notch in all of these cell types (Figure 2—figure supplement 2). Even in
two epithelial cell types, SC2 squamous cells and MB157 triple negative breast cancer cells, only
10.8% of Notch-responsive genes in SC2 cells were also Notch-responsive in MB157 cells. As would
be expected, the overlap between Notch-responsive genes in SC2 cells and B lineage REC1 cells (9/
390, 2.3%) and T lineage DND41 cells (1/390, 0.3%) was even lower. These observations serve to
again emphasize the remarkable context-specificity of Notch effects on gene expression.
Notch target genes are associated with lineage-specific NTC-binding
enhancer elements
To identify sites of NTC-binding to Notch-responsive regulatory elements in IC8-DEGF-L1596H cells,
we performed ChIP-seq for Notch transcription complex components (RBPJ and MAML1) 4 hr after
Notch activation, as well as for RBPJ prior to Notch activation. The rationale for identifying RBPJ
and MAML1-binding sites, rather than NOTCH1-binding sites, was several fold: (i) we wanted to
identify binding of endogenous Notch transcription complex components with reliable commercially
available monoclonal antibodies; (ii) based on our RNA-seq data sets, MAML1 is the most highly
expressed member of the MAML family in IC8 cells (MAML1 log2 read counts per million = 6.66;
MAML2 log2 read counts per million = 3.59; MAML3 log2 read counts per million = 0.70), and there-
fore was the logical member of the family to study; and (iii) we were intrigued by prior studies sug-
gesting that MAML1 might associate with non-Notch transcription factor complexes (Jin et al.,
2010; Quaranta et al., 2017; Shen et al., 2006; Zhao et al., 2007). In the Notch-on state, we found
that most MAML1 binding sites also bound RBPJ (8533/9,187 sites, 93%; Figure 3A), in line with
studies showing that MAML1 association with DNA requires both RBPJ and NICD (Nam et al.,
2006). Approximately 92% of RBPJ/MAML1 co-binding sites (hereafter designated NTC binding
sites) are in intergenic or intronic regions consistent with enhancers (Figure 3B). As predicted by
past studies (Castel et al., 2013; Krejcı́ and Bray, 2007; Ryan et al., 2017; Wang et al., 2014),
NTC binding was associated with increases in RBPJ ChIP-Seq signals and H3K27ac signals at pro-
moter and enhancer sites (Figure 3C), features previously noted to characterize ‘dynamic’ functional
Notch response elements. Motif analysis revealed that the most common motif lying within 300 bp
of NTC ChIP-Seq signals is that of RBPJ (Figure 3D), and that the motif for AP1, a factor not associ-
ated with NTC binding sites in other cell types (Chatr-Aryamontri et al., 2017; Drier et al., 2016;
Petrovic et al., 2019; Ryan et al., 2017; Wang et al., 2014), is also highly enriched in this 600 bp
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Table 2. Copy number variants, squamous cell carcinoma cell lines.
Chromosome Type Genes affected
IC8 cell line
1q Gain MCL1, GBA, RIT1, NTRK1, DDR2, PVRL4, SDHC,
CDC73, MDM4, PIK3C2B, UBE2T,
PTPN14, H3F3A, EGLN1, AKT3, EXO1, FH
2 Loss XPO1, FANCL, REL, MSH6, EPCAM, MSH2, SOS1,
ALK, BRE, DNMT3A, GEN1, MYCN, TMEM127,
GLI2, ERCC3, CXCR4, RIF1, ACVR1, ABCB11,
NFE2L2, PMS1, CASP8, SF3B1, CTLA4,
ERBB4, IDH1, BARD1, XRCC5, DIS3L2
3p Loss MITF, BAP1, PBRM1, COL7A1, RHOA, SETD2,
CTNNB1, MLH1, MYD88, XPC, PPARG,
RAF1, FANCD2, OGG1, VHL
3q Gain NFKBIZ, CBLB, POLQ, GATA2, MBD4, TOPBP1,
FOXL2, ATR, MECOM, PRKCI, TERC,
PIK3CA, SOX2, ETV5, BCL6
4 Loss PHOX2B, RHOH, SLC34A2, FGFR3, WHSC1, KDR,
KIT, PDGFRA, FAM175A, HELQ,
TET2, FBXW7, NEIL3, FAT1
5 Gain RICTOR, IL7R, SDHA, TERT, MAP3K1, PIK3R1,
XRCC4, RASA1, APC, RAD50, CTNNA1, PDGFRB,
ITK, NPM1, TLX3, FGFR4, NSD1, UIMC1, FLT4
6 Gain CCND3, NFKBIE, POLH, VEGFA, CDKN1A,
PIM1, RNF8, FANCE, DAXX, HFE, HIST1H3B,
HIST1H3C, ID4, PRDM1, ROS1, RSPO3, MYB,
TNFAIP3, ESR1, ARID1B, PARK2, QKI
7 Gain EGFR, IKZF1, JAZF1, ETV1, PMS2, RAC1,
CARD11, SBDS, CDK6, SLC25A13, CUX1, RINT1,
MET, POT1, SMO, BRAF, PRSS1, EZH2,
RHEB, XRCC2, PAXIP1
8p Loss KAT6A, POLB, FGFR1, WHSC1L1, NRG1,
WRN, NKX3-1, PTK2B, GATA4, NEIL2
8q11.21-q21.11 Loss PRKDC, MYBL1, TCEB1
8q21.3-q24.3 Gain NBN, RUNX1T1, RAD54B, RSPO2, EXT1,
RAD21, MYC, RECQL4
9p13.2-p21.3 Loss PAX5, FANCG, RMRP, CDKN2A, CDKN2B, MTAP
9p24.1-p24.3 Gain CD274, JAK2, PDCD1LG2, DOCK8
11p11.2-p13 Gain EXT2, LMO2
13q33.1 Loss ERCC5
15q Gain FAN1, GREM1, BUB1B, MGA, RAD51, TP53BP1,
B2M, USP8, MAP2K1, PML, NEIL1, FAH,
NTRK3, BLM, FANCI, IDH2, IGF1R
16p13.3 Loss CREBBP, SLX4
19 Loss BABAM1, CRTC1, JAK3, KLF2, MEF2B, BRD4,
NOTCH3, CALR, KEAP1, SMARCA4, ELANE,
GNA11, MAP2K2, STK11, TCF3, CCNE1,
C19orf40, CEBPA, AKT2, AXL, CIC, XRCC1,
ARHGAP35, ERCC1, ERCC2, BCL2L12,
PNKP, POLD1, PPP2R1A
20 Gain MCM8, ASXL1, BCL2L1, MAFB,
AURKA, ZNF217, GNAS, CDH4
SCCT2 Cell Line
1q32.1 Loss UBE2T
1q42.12-q42.2 Gain H3F3A, EGLN1
1q43 Loss AKT3, EXO1
1q43 Gain FH
Table 2 continued on next page
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window. Based on the method of Severson et al., 2017, approximately 13% of NTC-binding sites in
IC8 cells are predicted to be sequence paired sites (Figure 3E), a specialized type of response ele-
ment that binds NTC dimers (Arnett et al., 2010). Finally, particularly at early time points, NTC-
binding sites were spatially associated with genes that are upregulated by Notch, whereas genes
that decreased in expression were no more likely to be associated with NTC binding sites than
genes that did not change in expression (Figure 3F). Taken together, these studies show that NTCs
mainly bind lineage-specific enhancers in SCC cells and that their loading leads to rapid ‘activation’
of Notch-responsive elements and upregulation of adjacent genes.
We also performed motif analysis on sites producing significant signals for only RBPJ or only
MAML1. RBPJ ‘only’ sites also were enriched for RBPJ (E value 1.3e-124) and AP1 (E value 2.8e-71)
motifs but had lower average ChIP-Seq signals, suggesting these may be weak RBPJ-binding sites.
MAML1 ‘only’ sites also were enriched for AP1 motifs (E value 2.9e-181) but were not associated with
RBPJ motifs. These sites were relatively few in number (N = 654) and the associated AP1 motifs
were distributed broadly around MAML1 signal peaks, arguing against direct physical interaction
between MAML1 and AP1 family members on chromatin. Thus, the significance of these ‘MAML1-
only’ peaks is uncertain, and it is possible that the observed ChIP-seq signals are non-specific, stem-
ming from over-representation of ‘open’ chromatin in ChIPs.
IER5 is a direct Notch target gene
We were intrigued by the convergence of Notch target genes, which presumably serve to promote
and coordinate keratinocyte differentiation, and genes linked to DNA damage/cell stress responses.
We selected one gene of this class, IER5, a member of the immediate early response gene family,
for detailed analysis based on prior work implicating IER5 in cellular responses to DNA damaging
agents and heat shock (Ding et al., 2009; Ishikawa and Sakurai, 2015; Kis et al., 2006), as well as
functional studies suggesting that IER5 is a modulator of the serine/threonine kinase PP2A
(Asano et al., 2016; Ishikawa et al., 2015; Kawabata et al., 2015) and might therefore serve as
point of crosstalk between Notch and signaling pathways that depend on serine/threonine phos-
phorylation for signal transduction.
To confirm that IER5 is also upregulated by activation of endogenous Notch signaling in non-
transformed keratinocytes, we studied TERT-immortalized NOK1 keratinocytes, which undergo squa-
mous differentiation when moved to high Ca2+ medium (Piboonniyom et al., 2003). We observed
that differentiation of NOK1 cells significantly increased the expression of IER5 as well as the canoni-
cal Notch target gene NRARP, effects that were blocked by GSI and by DN-MAML1, confirming that
the observed changes in gene expression are Notch-dependent (Figure 4—figure supplement 1A
and B). In line with the Notch-dependent increases in IER5 transcripts upon induction of differentia-
tion, we also observed that IER5 protein levels increased in differentiation medium in a GSI- and
DN-MAML1-sensitive fashion (Figure 4—figure supplement 1C and D). Differentiation was
Table 2 continued
Chromosome Type Genes affected
3 p Arm level Loss MITF, BAP1, PBRM1, COL7A1, RHOA, SETD2,
CTNNB1, MLH1, MYD88, XPC,
PPARG, RAF1, FANCD2, OGG1, VHL
3q Arm level Gain NFKBIZ, CBLB, POLQ, GATA2, MBD4, TOPBP1,
FOXL2, ATR, MECOM, PRKCI,
TERC, PIK3CA, SOX2, ETV5, BCL6
8q Arm level Gain PRKDC, MYBL1, TCEB1, NBN, RUNX1T1,
RAD54B, RSPO2, EXT1, RAD21, MYC, RECQL4
9q Arm level Gain GNAQ, NTRK2, FANCC, PTCH1, GALNT12, XPA,
KLF4, TAL2, ENG, ABL1, TSC1, BRD3, NOTCH1
18q11.2 Gain GATA6, RBBP8
18q11.2-q21.33 Gain SS18, SETBP1, SMAD2, SMAD4, BCL2
20 Gain MCM8, ASXL1, BCL2L1, MAFB, AURKA, ZNF217,
GNAS, CDH4
Pan et al. eLife 2020;9:e58081. DOI: https://doi.org/10.7554/eLife.58081 10 of 32
Research article Cancer Biology Cell Biology
0
1
2
3
0h 1h 2h 4h 24
h
pB
AB
E
ID3
0
2
4
6
8
0h 1h 2h 4h 24
h
pB
AB
E
0
1
2
3
4
5
0h 1h 2h 4h 24
h
pB
AB
E
0
1
2
3
4
0h 1h 2h 4h 24
h
pB
AB
E
Differentially expressed genes
GO Term FDR (%–log10)
Neg. reg. of endopeptidase 4.36
Endopeptidase inh. activity 2.92
Keratinocyte differentiation 3.90
Peptide crosslinking 3.22
-10   -5     0     5     10 -10   -5     0     5     10 -10   -5     0     5     10
4hr 24hr 72hr
0
200
100
300
-L
o
g
1
0
F
D
R
Log2 Fold Change
0
2
4
6
8
10
0h 1h 2h 4h 24
h
pB
AB
E
HES1
R
e
la
ti
v
e
 R
N
A
 E
x
p
re
s
s
io
n
0
2
4
6
8
0h 1h 2h 4h 24
h
pB
AB
E
HES4
0
20
40
60
80
100
120
0h 1h 2h 4h 24
h
pB
AB
E
HES5
0
20
40
60
80
0h 1h 2h 4h 24
h
pB
AB
E
NRARP
0
4
8
12
16
20
0h 1h 2h 4h
24
h
pB
AB
E
RHOV
R
e
la
ti
v
e
 R
N
A
 E
x
p
re
s
s
io
n
RIPK4 IRF6
0
4
8
12
16
0h 1h 2h 4h
24
h
pB
AB
E
CCN1
0
2
4
6
0h 1h 2h 4h 24
h
pB
AB
E
R
e
la
ti
v
e
 R
N
A
 E
x
p
re
s
s
io
n
IER5 GADD45A
ICN1
IER5
ID3
Actin
WO    - +     - +
EV DN-MAML
A
B
C
D
E F
GADD45A
Figure 2. Identification of Notch-induced genes in squamous carcinoma cells. (A) Volcano plots showing changes in RNA transcript read counts
induced by Notch activation in SC2 cells for 4, 24, and 72 hr as compared to control cells treated with sham GSI washout. RNA-seq for each treatment
group was performed in triplicate on biological replicates. Vertical lines denote a twofold change in read count, while the horizontal line denotes a false
discovery rate (FDR) of 5%. (B) Gene ontogeny (GO) annotation of differentially expressed genes in ‘Notch-on’ SC2 cells. The most highly associated
Figure 2 continued on next page
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accompanied by activation of NOTCH2 and NOTCH3 (inferred from the accumulation of smaller pol-
ypeptides consistent with ADAM cleavage products under differentiation conditions in the presence
of GSI; Figure 4—figure supplement 1C and D), as well as increased expression of NOTCH3, a
known target of activated Notch. Suppression of IER5 transcript levels by GSI in some experiments
was less pronounced than the abrogation of the accumulation of IER5 protein by Notch inhibitors,
suggesting that additional pathways influence IER5 expression (consistent with the complex
enhancer landscape around this gene) and that Notch signaling may regulate IER5 both transcrip-
tionally and post-transcriptionally. Unexpectedly, we did not observe any activation of NOTCH1 in
NOK1 cells in differentiation medium (data not shown), suggesting that differentiation in this model
is directed by NOTCH2 instead of NOTCH1. Notably, given that germline swaps of the coding
sequences of the intracellular domains of NOTCH1 and NOTCH2 yield apparently normal mice
(Liu et al., 2015), it is likely that NOTCH1 and NOTCH2 activate the same sets of target genes,
including IER5 in keratinocytes.
We next sought to confirm that IER5 is a direct Notch target gene. Inspection of chromatin land-
scapes around IER5 in IC8 cells revealed a series of flanking enhancers, two of which (D and E)
showed the largest RBPJ/MAML1 signals and the greatest increase in H3K27ac following Notch acti-
vation (Figure 4A), a dynamic change that is strongly correlated with increased transcription of flank-
ing genes (Wang et al., 2014). Notably, a similar enhancer landscape exists in non-transformed
human keratinocytes (Figure 4—figure supplement 1E), and expression of IER5 transcripts is readily
detectable in normal human skin (Figure 4—figure supplement 1F-H), consistent with the idea that
the observed enhancers are involved in physiologic regulation of IER5 in keratinocytes. Reporter
gene assays with enhancers D and E in IC8-DEGF-L1596H cells (Figure 4B and C, respectively) con-
firmed that the Notch responsiveness of these elements depend on RBPJ-binding sites and also
showed, in the case of enhancer D, that a flanking AP1 consensus site is also required. To determine
the contributions of enhancers D and E within the genomic IER5 locus, we used CRISPR/Cas9 target-
ing to delete the regions containing RBPJ-binding sites in these two enhancers in SC2 cells
(Figure 4D). These deletions partially abrogated the Notch-dependent increase in IER5 transcription
(Figure 4E) and suppressed the accumulation of IER5 protein following Notch activation (Figure 4F),
confirming that IER5 is directly regulated by Notch through these elements.
IER5 is required for ‘late’ Notch-dependent differentiation events in
squamous cells
To systematically determine the contribution of IER5 to Notch-dependent changes in gene expres-
sion, we compared the transcriptional response to Notch activation in SC2 cells, SC2 cells in which
IER5 was knocked out (I5 cells), and I5 cells to which IER5 expression was added back (I5AB cells,
Figure 5A). Different doses of IER5 had no effect on gene expression in the absence of Notch sig-
naling, or on the expression of genes that are induced by Notch within 4 hr (Figure 5B, denoted
with a blue box); however, by 24 hr and 72 hr of Notch activation, I5 cells failed to upregulate a large
group of Notch-responsive genes that were rescued by add-back of IER5 (Figure 5B, denoted with
a red box). GO analysis revealed that IER5-dependent genes were associated with various aspects of
keratinocyte differentiation and biology (Figure 5C; summarized in Supplementary files 7 and
8). An example of a differentiation-associated gene impacted by loss of IER5 is KRT1, a marker of
spinous differentiation, expression of which is markedly impaired by IER5 knockout and restored by
Figure 2 continued
GO terms are shown; other significant associated annotated gene sets (FDR < 5%) are listed in Supplementary file 7. (C-E) Transcriptional responses
of selected ‘canonical’ Notch target genes (C), genes linked to keratinocyte differentiation (D), and genes associated with DNA damage responses (E),
to Notch activation in IC8-DEGF-L1596H cells. Transcript abundance in technical replicates prepared in triplicate was measured by RT-PCR and
normalized against GAPDH. Error bars represent standard deviations of the mean. (F) Western blots of cell lysates prepared from IC8-DEGF-L1596H
cells transduced with empty virus (EV) or DN-MAML following sham GSI washout (-) or 24 hr post-GSI washout (+).
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. GSI treatment has little effect on gene expression in IC8 squamous carcinoma cells.
Figure supplement 2. Venn diagram showing the overlap in Notch target genes (defined as log2 change >1 and FDR < 0.05 following GSI washout) in
IC8 squamous carcinoma cells (S2 subclone), MB157 triple negative breast carcinoma cells (Petrovic et al., 2019), REC1 mantle cell lymphoma cells
(Ryan et al., 2017), and DND-41 T-ALL cells (Petrovic et al., 2019).
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Figure 3. Characterization of Notch transcription complex (NTC) binding sites in IC8-DEGF-L1596H cells. (A) Number and overlap of RBPJ and MAML1
binding sites determined by ChIP-Seq of chromatin prepared 4 hr after Notch activation. (B) Genomic distribution of RBPJ/MAML1 co-binding sites 4 hr
after Notch activation. TTS, transcription termination sites; ncRNA, non-coding RNA. (C) Effect of NTC loading on histone3 lysine27 acetylation
(H3K27ac), based on ChIP-Seq for H3K27ac in cells maintained in GSI and in cells 1, 2, and 4 hr after GSI washout. (D) Transcription factor motifs
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IER5 add-back (Figure 5D). Similarly, IER5 was required for Notch-dependent expression of the late
marker involucrin in 3D cultures (Figure 5G). Thus, IER5 is necessary but not sufficient for expression
of a group of genes that respond to Notch with delayed kinetics.
To extend these observations to non-transformed keratinocytes that rely on endogenous Notch
signaling for differentiation, we targeted IER5 with CRISPR/Cas9 and also enforced expression of
IER5 through retroviral transduction in NOK1 cells. Although CRISPR/Cas9 targeting of bulk NOK1
cells was only partially effective, it was sufficient to diminish the expression of multiple differentia-
tion-associated genes (Figure 5F), whereas overexpression of IER5 increased expression of each of
these markers (Figure 5G). Thus, IER5 is required for Notch-dependent differentiation of malignant
and non-transformed keratinocytes.
IER5 binds B55a/PP2A complexes
IER5 encodes a 327 amino acid protein with a ~ 50 amino acid N-terminal IER domain and a C-termi-
nal domain predicted to be unstructured, suggesting that it functions through protein-protein inter-
actions. To identify interacting proteins in an unbiased way, we expressed a tagged form of IER5 in
IER5 null I5 cells and performed affinity purification followed by mass spectrometry
(Adelmant et al., 2019), which identified the B55a regulatory subunit of PP2A (encoded by the
PPP2RA2 gene) and PP2A scaffolding and catalytic subunits as potential interactors (Figure 6A;
summarized in Supplementary file 9). We confirmed these associations by expressing tagged IER5
in I5 cells and tagged B55a in SC2 cells (Figure 6B). Full-length IER5 and the N-terminal IER domain
of IER5 co-precipitated endogenous B55a in Notch-independent fashion, whereas the C-terminal
portion of IER5 did not (Figure 6C). Similarly, tagged B55a co-precipitated endogenous IER5 in a
fashion that was augmented by Notch activation (Figure 6D), consistent with increased recovery of
IER5 due to induction of IER5 expression by Notch. To confirm that IER5 binds B55a directly, we
studied the interaction of purified recombinant proteins. IER5 exhibited saturable binding to B55a-
coated beads (Figure 6E), and additional microscale thermophoresis studies showed that IER5 binds
B55a with a Kd of approximately 100 nM (Figure 6F).
IER5 is epistatic to PPP2R2A in SCC cells
To gain insight into the role of IER5-B55a interaction in the regulation of Notch- and IER5-sensitive
genes, we prepared SCC cells that were knocked out for IER5, PPP2R2A, or both genes (Figure 7A).
Knockout of PPP2R2A did not affect the levels of ICN1 following GSI washout (Figure 7A), but
markedly increased the expression of the late differentiation gene KRT1 in 2D culture (Figure 7B)
and the accumulation of involucrin in 3D cultures (Figure 7C), effects that were suppressed by add-
back of B55a, suggesting a model in which IER5 suppresses a B55a-dependent activity. This was
supported by assays performed with IER5/PPP2R2A double knockout cells (Figure 7A), in which
expression of the late genes such as KRT1 was also restored (Figure 7D). These results suggest that
Notch modulation of B55a-PP2A activity via IER5 is important in regulating the complex series of
events downstream of Notch that lead to squamous cell differentiation.
Discussion
Our work provides a genome-wide view of the direct effects of Notch in SCC cells, in which Notch
activation induces growth arrest and differentiation. The phenotypic changes induced by Notch are
mediated by a largely squamous-cell-specific transcriptional program that includes genes linked to
keratinocyte differentiation and DNA damage responses, including IER5, which modulates the activ-
ity of B55a-containing PP2A complexes. Upregulation of these Notch-responsive genes are associ-
ated with binding of NTCs to RBPJ sites within lineage-specific enhancers, including a minority of
sequence-paired sites, a specialized dimeric NTC binding element recently implicated in anti-
Figure 3 continued
enriched within 300 bp of RBPJ/MAML1 ChIP-Seq signal peaks. (E) Protein-binding matrix (PBM) X PBM scores for NTC-binding sites. Sites with scores
in the right-hand Gaussian distribution correspond to likely sequence paired sites. (F) Kolmogorov-Smirnov analysis showing spatial relationships
between NTC-binding sites and transcriptional start sites (TSSs) of genes that increase, decrease, or are unchanged in expression following Notch
activation. The gray zone denotes genes with TSSs within 2 kb of RBP/MAML1 peaks.
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Figure 4. IER5 is a direct Notch target gene. (A) Chromatin landscapes around IER5 in IC8-DEGF-L1596H cells. ChIP-Seq signals for RBPJ, MAML1, and
H3K27ac for cells maintained in and 4 hr after GSI washout (WO) are shown. (B, C) Activities of a WT IER5 enhancer E luciferase reporter gene and
derivatives bearing mutations (m) in two RBPJ consensus motifs (B) and a WT IER5 enhancer D luciferase reporter gene and derivatives bearing
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parasite immune responses in mice (Kobia et al., 2020). The Notch target genes and elements iden-
tified here in malignant squamous cells are likely to be relevant for understanding Notch function in
non-transformed squamous cells, as many of the NTC-binding enhancers found near Notch target
genes in SCC cells are also active in normal human keratinocytes (based on review of ENCODE data
for non-transformed human keratinocytes). These observations have a number of implications for
understanding how Notch regulates the growth and differentiation of squamous cells and highlight
the potential for Notch to influence the activity of diverse signaling pathways in keratinocytes
through modulation of PP2A.
Prior work has suggested that p53-mediated upregulation of Notch expression and activity is a
component of the DNA damage response in keratinocytes (Mandinova et al., 2008). Conversely,
our work shows that Notch activation, even in a TP53 mutant background, induces the expression of
genes that are components of the keratinocyte DNA damage/cell stress response, suggesting that
these two pathways converge on a set of genes that induce the differentiation (and thus, the elimina-
tion) of damaged cells. Consistent with this idea, recent work has shown that low-dose radiation
induces the differentiation of esophageal squamous cells at the expense of self-renewal in vivo (Fer-
nandez-Antoran et al., 2019). The frequent co-mutation of TP53 and Notch genes in squamous car-
cinoma may also reflect, at least in part, the convergence of these pathways on a core set of genes
with anti-oncogenic activities. Further work delineating the crosstalk between p53 and Notch signal-
ing in well controlled model systems will be needed to test this idea.
Among the genes linked to Notch and p53 is IER5, an immediate early response gene that is a
component of the DNA-damage response in a number of cell types (Ding et al., 2009; Kis et al.,
2006; Kumar et al., 1998; Yang et al., 2016). Several lines of investigation suggest that IER5 modu-
lates the function of PP2A complexes containing B55 (Asano et al., 2016; Ishikawa et al., 2015;
Kawabata et al., 2015) regulatory subunits, and here we demonstrate that IER5 directly binds B55a
protein in a purified system. However, the exact effect of IER5 on PP2A function is uncertain. One
model suggests that IER5 augments the ability of B55/PP2A complexes to recognize and dephos-
phorylate specific substrates such as S6 kinase and HSF1 (Ishikawa et al., 2015; Kawabata et al.,
2015), the latter leading to HSF1 activation as part of the heat shock response. However, our work
with double knockout cells suggests IER5 inhibits at least some activities that are attributable to
B55a-containing PP2A complexes. Work in purified systems, which is now feasible, may help to clar-
ify how IER5 influences B55/PP2A function.
We also note that IER3, a putative regulator of B56/PP2A complexes, behaves as a direct Notch
target in our SCC model system. Given the pleotropic role of PP2A isoforms and their myriad sub-
strates, it appears likely that Notch-dependent modulation of PP2A regulators such as IER5 and IER3
will alter the activity of many factors that are regulated by serine/threonine phosphorylation.
Because IER5 is required for expression of a large number of Notch-sensitive genes with delayed
response kinetics, B55a/PP2A complexes are likely to regulate one or more transcription factors that
coordinately induce squamous differentiation with Notch, another idea that is readily testable in our
model system.
Finally, we note that our small screen of SCC cell lines suggests that squamous cell carcinomas
retain the capacity to respond to Notch signals by undergoing growth arrest and differentiation.
Although originally identified as an oncogene, sequencing of cancer genomes has revealed that
Notch most commonly acts as a tumor suppressor, particularly in squamous cell carcinoma, which is
Figure 4 continued
or 24 hr after GSI washout (WO). Luciferase reporter gene activity was determined in biological replicates prepared in triplicate and normalized to the
activity of a Renilla luciferase internal control gene. Error bars represent standard deviations. (D) Cartoon showing the CRISPR/Cas9 targeting strategy
for IER5 enhancers D and E. (E) Relative IER5 transcript levels in SC2 cells targeted with control AAVS1 CRISPR/Cas9 plasmids (SC2/con) or with
CRISPR/Cas9 plasmids that remove the RPBJ sites in enhancers D and E (SC2/DD+E). Cells were either maintained in GSI or were harvested 2 hr
following GSI washout (WO). Transcript abundance was measured in experimental triplicates by RT-PCR and normalized against GAPDH. Error bars
represent standard errors of the mean. (F) Western blots showing IER5 protein levels in SC2/con cells and SC2/DD+E cells that were either maintained
in GSI or harvested 1, 2, or 4 hr following GSI washout (WO). In B, C, and E, *, p<0.05; **, p<0.005; ***, p<0.0005 (all two-tailed student t test); NS, not
significant.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. IER5 is regulated by Notch in non-transformed keratinocytes.
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Figure 5. Effect of IER5 on Notch-dependent changes in gene expression in SC2 cells and NOK1 cells. (A) Western blots showing IER5 and ICN1
protein levels in SC2 cells, a single-cell clone derived from SC2-IER5 knockout cells (I5KO), I5KO cells transduced with empty virus (I5/con), and pooled
I5KO cells transduced with IER5 cDNA (I5AB) that were maintained in GSI (-) or harvested 48 hr post-GSI washout (+). (B) Heat map showing Notch-
induced changes in gene expression in SC2 cells, I5KO cells, and I5AB cells. RNA-seq was performed in biological replicates in triplicate at time 0, 4 hr,
Figure 5 continued on next page
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difficult to treat when advanced in stage. While restoring the expression of defective Notch recep-
tors is problematic, detailed analysis of crosstalk between Notch and other pathways may reveal
druggable targets leading to reactivation of tumor suppressive signaling nodes downstream of
Notch, which would constitute a new rational therapeutic approach for squamous cancers.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Antibody Rabbit monoclonal
anti-MAML1
Cell Signaling
Technology
Cat. #: 12166 ChIP, 1 ml per
1  106 cells
Antibody Rabbit monoclonal
anti-RBPJ
Cell Signaling
Technology
Cat. #: 5313 ChIP, 2.5 ml per
1  106 cells
Antibody Rabbit polyclonal
anti-histone
H3 acetyl K27
Abcam Cat. #: ab4729 ChIP, 9 ml per
1  106 cells
Antibody Mouse monoclonal
anti-involucrin
Sigma Cat. #: I9018 IF, 1:500;
IHC, 1:10,000
Antibody Rabbit polyclonal
anti-plakophilin-1
Sigma Cat. #: HPA027221 IF, 1:300;
IHC, 1:500
Antibody Rabbit monoclonal
anti-activated
NOTCH1 (ICN1)
Cell Signaling
Technology
Cat. #: 4147 IHC, 1:50;
WB, 1:1000
Antibody Rabbit monoclonal
anti-keratin-1
Abcam Cat. #: ab185628 IHC, 1:1000
Antibody Rabbit monoclonal
anti-Ki-67
Biocare Cat. #: CRM325 IHC, 1:100
Antibody Mouse monoclonal
anti-B55a
Cell Signaling
Technology
Cat. #: 5689 WB, 1:1000
Antibody Rabbit monoclonal
anti-NOTCH2
Cell Signaling
Technology
Cat. #: 5732 WB, 1:1000
Antibody Rabbit monoclonal
anti-NOTCH3
Cell Signaling
Technology
Cat. #: 5276 WB, 1:1000
Antibody Rabbit monoclonal
anti-GADD45A
Cell Signaling
Technology
Cat. #: 4632 WB, 1:1000
Antibody Rabbit monoclonal
anti-ID3
Cell Signaling
Technology
Cat. #: 9837 WB, 1:1000
Continued on next page
Figure 5 continued
24 hr, and 72 hr after GSI washout. Samples were subjected to unsupervised clustering using a gene set containing all genes that were significantly
upregulated at any time point after Notch activation in SC2 cells. The blue boxes highlight genes that are upregulated at 4, 24, and 72 hr after Notch
activation, whereas the red box highlights genes that are under-expressed in IER5 knockout cells (I5KO) and rescued by re-expression of IER5 (I5AB) at
later timepoints (24 and 72 hr). (C) Gene ontogeny (GO) terms associated with the set of under-expressed genes in I5KO cells following Notch
activation. FDR = false discovery rate. (D) Diminished induction of KRT1 expression at 24 and 72 hr after GSI WO in I5KO cells is prevented by IER5
addback (I5AB cells). Transcript abundance in biological replicates prepared in triplicate was measured by RT-PCR and normalized against GAPDH.
Error bars represent standard deviations of the mean. *, p<0.05; **, p<0.005; NS, not significant (two-tailed student t test). (E) Immunohistochemical
staining for involucrin in SC2, I5KO, and I5AB cells in raft cultures grown in the absence of GSI. (F, G) Effect of CRISPR/Cas9 targeting of IER5 and
enforced IER5 expression on differentiation-associated transcripts in NOK1 cells. In F, NOK1 cells were transduced with CRISPR/Cas9, GFP, and IER5
(I5KO) gRNA or AAVS1 control (con) gRNA and sorted for GFP positivity. In G, NOK1 cells were transduced with empty GFP-expressing retrovirus (con)
or IER5 and GFP and sorted. In F and G, analyses were done on pooled GFP-positive transductants, which were moved to high Ca2+ medium for 3
days (F) or 5 days (G) prior to harvest. Inset western blots show the extent of IER5 loss (F) and IER5 overexpression (G) relative to control cells. In F and
G, transcript abundance was measured in biological replicates prepared in triplicate by RT-PCR and normalized against GAPDH. Error bars represent
standard deviations of the mean. *, p<0.05, student two-sided t test.
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Antibody Horse polyclonal
anti-mouse
Ig linked to HRP
Cell Signaling
Technology
Cat. #: 7076 WB, 1:1,000
-1:20,000
Antibody Goat polyclonal
anti-rabbit
Ig linked to HRP
Cell Signaling
Technology
Cat. #: 7074 WB, 1:1000
Antibody Mouse monoclonal
anti-actin
Sigma Cat. #: A1978 WB, 1:10,000
Antibody Mouse monoclonal
anti-FLAG
Sigma Cat. #: F3165 WB, 1:1000
Antibody Rabbit polyclonal
anti-IER5
Sigma Cat. #: HPA029894 WB, 1:1000
Antibody Mouse monoclonal
anti-filaggrin
Santa Cruz
Biotechnology
Cat. #: sc-66192 IHC, 1:100
Antibody Mouse monoclonal
anti-p63
Biocare Medical Cat. #: CM163A IHC, 1:250
Antibody Rabbit polyclonal
anti-loricrin
BioLegend Cat. #: 905103 IHC, 1:800
Antibody Mouse monoclonal
anti-BCL6
Cell Marque
Tissue Diagnostics
Cat. #: 227 M-95 IHC, 1:500
Antibody Rabbit monoclonal
anti-keratin5
Cell Signaling
Technology
Cat. #: 71536 IHC, 1:2000
Antibody Chicken polyclonal
anti-keratin14
BioLegend Cat. #: 906004 IHC, 1:800
Antibody Chicken polyclonal
anti-SUMO
Lifesensors Cat. #: AB7002 WB, 1:2000
Antibody Sheep polyclonal
anti-rabbit
Ig linked to Dynabeads
ThermoFisher
Scientific
Cat. #: 11203D ChIP, 100 ml beads
per 20  106 cells
Antibody Mouse monoclonal
anti-FLAG
epitope linked to
magnetic beads
Sigma Cat #: M8823 Tandem purification,
40 ml to 1 ml beads
Cell line
(Homo sapiens)
IC8 10.1038/s41467-
018-06027-1
Dr. Andrew South
(Thomas Jefferson
University)
Cell line
(H. sapiens)
SCCT2 10.1038/s41467-
018-06027-1
Dr. Andrew South
(Thomas Jefferson
University)
Cell line
(H. sapiens)
NOK1 Piboonniyom et al., 2003;
63:476–83
Dr. Karl Munger
(Tufts University)
Commercial
assay or kit
CellTiter Blue Promega Cat. #: G8080
Commercial
assay or kit
ChIP Assay Kit Millipore Cat. #: 17–295
Commercial
assay or kit
Next Ultra II DNA
Library Prep Kit
New England
BioLabs
Cat. #: E7645
Commercial
assay or kit
Next Ultra II RNA
Library Prep Kit
New England
BioLabs
Cat. #: E7775
Commercial
assay or kit
QuickChange II Kit Agilent
Technologies
Cat. #: 200523
Commercial
assay or kit
Dual Luciferase Kit Promega Cat. #: E1910
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Chemical
compound, drug
Compound E Tocris Cat. #:
CAS 209986-17-4
Recombinant
DNA reagent
pL-CRISPR.
SFFV.GFP
Addgene Cat. #: #57827
Recombinant
DNA reagent
pL-CRISPR.SFFV.tRFP Addgene Cat. #: #57826
Recombinant
DNA reagent
lentiCRISPRv2 neo Addgene Cat. #: 98292
Recombinant
DNA reagent
lentiCRISPRv2 hygro Addgene Cat. #: 98291
Recombinant
DNA reagent
pVL1392 Expression
Systems
Cat. #: 91–012
Cell lines and 2D cultures
Cells were grown under 5% C02 at 37˚C in media supplemented with glutamine and streptomycin/
penicillin. IC8 cells (Wang et al., 2011) were cultured in Keratinocyte medium as described
(Purdie et al., 2011). DEGF-L1596H cDNA cloned into pBABE-puro was packaged into pseudotyped
retrovirus and used to transduce IC8 and SCCT2 cells, which were selected with puromycin (1 mg/
ml). In some instances, cells were also transduced with pseudotyped MigRI retrovirus encoding dom-
inant negative MAML1 fused to GFP (Weng et al., 2003). Single-cell IC8 cell clones were isolated by
limiting dilution. NOK1 cells were grown in keratinocyte-SFM medium supplemented with human
EGF and bovine pituitary extract (BPE) (Thermo Fisher Scientific) and induced to differentiate by
transfer to Dulbcecco modified Eagle medium (DMEM) containing 10% fetal bovine serum. The iden-
tity of IC8 cells and SCCT2 cells was confirmed by detection of cell-line-specific ‘private’ driver muta-
tions (Inman et al., 2018) by NextGen sequencing. The identity of NOK1 cells was confirmed by STR
testing (Genetica Cell Line Testing, Case # CX4-007937). Culture cells were tested for mycoplasma
periodically using the LookOut Mycoplasma PCR Detection Kit (Millipore Sigma, Cat. #MP0035).
To determine the effect of collagen matrix on ICN1 levels, 5  104 cells were plated in the pres-
ence of GSI in standard Corning six-well plates or Corning Biocoat Collagen 6-well plates coated
with rat tail collagen 1. After 4 days, cells were subjected to GSI washout or sham GSI washout and
cultured for an additional 24 hr.
Cell growth assays
Cell numbers were estimated using CellTiter Blue (Promega) per the manufacturer’s recommenda-
tions. Fluorescence was measured using a SpectraMax M3 microplate reader (Molecular Devices).
Organotypic 3D cultures
3D raft cultures were performed on a matrix containing 5  105 J2 3T3 fibroblast cells and rat colla-
gen as described (Arnette et al., 2016). Briefly, rafts were allowed to mature for 6–7 days and then
were seeded with 5  105 SCC cells in E-medium in the presence of GSI. After 2 days, rafts were
raised to the fluid-air interface, and medium was refreshed + / - GSI every 2 days for a total of 12
additional days.
Targeted exon sequencing
NGS was performed on IC8 and SCCT2 cell genomic DNA using the ‘oncopanel’ assay (Abo et al.,
2015; Wagle et al., 2012), which covers 447 cancer genes. Briefly, DNA (200 ng) was enriched with
the Agilent SureSelect hybrid capture kit and used for library preparation. Following sequencing (Illu-
mina HiSeq 2500), reads were aligned to human genome GRCh37 (hg19) (Li and Durbin, 2009),
sorted, duplicate marked, and indexed. Base-quality score calibration and alignments around indels
was done with Genome Analysis Toolkit (DePristo et al., 2011; McKenna et al., 2010). Single-nucle-
otide variant calls were with MuTect (Cibulskis et al., 2013). Copy number alterations were deter-
mined using RobustCNV. Structural variants were detected using BreaKmer (Abo et al., 2015).
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Preparation of ChIP-Seq and RNA-seq libraries
Chromatin was prepared as described (Wang et al., 2014) and was immunoprecipitated with anti-
bodies against MAML1 (clone D3K7B) or RBPJ (clone D10A11, both from Cell Signaling Technology)
and Dynabeads bearing sheep anti-rabbit Ig (Thermo Fisher Scientific). H3K27ac ChIPs were pre-
pared using the ChIP assay kit (Millipore) and H2K27ac antibody (ab4729, Abcam). ChIP-seq libraries
were constructed using the NEBNext Ultra II DNA Library Prep Kit (New England BioLabs). Total
RNA was prepared with Trizol (Life Technology) and RNeasy Mini columns (Qiagen). RNA libraries
were constructed using the NEBNext Ultra II RNA Library Prep kit (New England BioLab). ChIP-seq
and RNA-seq libraries were sequenced on an Illumina NextSeq 500 instrument. ChIP-seq and RNA-
seq data sets are deposited in GEO (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE156488).
For Figure 2—figure supplement 1, IC8 cells were seeded at 6  105 cells per 10 cm dish. The
next morning, media was changed to media containing GSI (Compound E, 1 mM) or an equivalent
volume of DMSO. One day after the media change, cells were lifted from the dish with trypsin con-
taining 1 mM GSI or an equivalent volume of DMSO and washed with PBS containing 1 mM GSI or
vehicle (DMSO), and 106 cells were pelleted and resuspended in TRIzol (Thermo Fisher). Two biolog-
ical replicates were collected per condition. RNA Spike-in standards (Invitrogen, 1 mL of 1:10 diluted
ERCC) were added to each tube of RNA in TRIzol. Total RNA was extracted by phenol/chloroform
with MaXtract tubes (Qiagen). RNA quality was assessed by HS RNA ScreenTape on an Agilent Tape
Station. Libraries were constructed using the TruSeq Stranded Total RNA Library Prep Gold kit (Illu-
mina) at the HMS Nascent Transcriptomics Core. Samples were sequenced for paired end reads on
the Illumina NovaSeq at the Harvard Bauer Center Sequencing Core, using the S1 Flow Cell and the
100 Cycle Kit. RNA-seq data sets for IC8 cells treated with vehicle or GSI are available at https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156624.
ChIP-seq data analysis
Reads were trimmed with Trim Galore (v.0.3.7 using cutadapt v.1.8), assessed for quality with
FastQC (v.0.11.3), and aligned to GRCh38/hg38 with bowtie (v.2.0.0; Langmead and Salzberg,
2012). Peaks were identified using MACS2 (v.2.1.1; Zhang et al., 2008) and annotated using Homer
(v3.12, 6-8-2012; Heinz et al., 2010). Peaks mapping to repeats (repeatMasker track, from UCSC) or
ENCODE blacklisted regions were removed. Overlapping RBPJ and MAML1 peaks were identified
with bedtools intersectBed (v2.23.0; Quinlan and Hall, 2010). Motif analysis was performed using
MEME-ChIP (Machanick and Bailey, 2011). Average signal profiles were generated with ngsplot
(Shen et al., 2014). RBPJ sequence-paired sites (SPSs) were identified as described (Severson et al.,
2017). Mixed Gaussian curves were generated in R using the mixtools (v.1.1.0) function
(Benaglia et al., 2009).
RNA-seq data analysis
Reads were trimmed as described for DNA reads and aligned to human genome GRCh38/hg38
using gencode release 27 annotations and STAR (v.2.5.3a) (Dobin et al., 2013). Raw counts from
two sequencing runs were loaded into R (R Development Core Team, 2014), summed, and filtered
to exclude transcripts with <0.5 reads per million mapped before performing differential expression
(DE) analysis with edgeR (v.3.16.5) and RUVSeq (v.1.8.0) (Risso et al., 2014). After first-pass DE anal-
ysis, a control set of 733 genes with FDR > 0.5 in all pairwise comparisons was used with RUVg
(k = 1) to identify unwanted variation. Second-pass edgeR analysis included the RUVg weights in the
model matrix. Genes with FDR < 5% and absolute logFC >1 were retained for further analysis.
DAVID v.6.8 (Huang da, Huang et al., 2009) was used for gene ontology (GO) enrichment analysis
of the DE gene lists. EdgeR cpm function with library size normalization and log2 conversion was
used to generate expression values, which were displayed using pheatmap (R package version
1.0.8). Other plots were made using in-house R scripts (available upon request).
For Figure 2—figure supplement 1, sequencing reads were filtered to retain reads with an aver-
age quality score 20 and were then mapped to hg38 with Ensembl release 99 annotations using
Star version 2.7.0 f. (Dobin et al., 2013). Duplicated reads were removed. ERCC spike-in reads were
mapped using Bowtie version 1.2.2 (Langmead et al., 2009). The percentage of reads mapping to
the spike-in was not significantly different between samples. To identify differentially expressed
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genes, the featureCounts function (Liao et al., 2014) in Rsubread version 2.0.1 (Liao et al., 2019)
was used in R version 3.6.2 to assign reads to Ensembl release 99 gene annotations. Differential
gene expression was performed with DESeq2 version 1.26.0 in R (Love et al., 2014), using the size
factors calculated by DESeq2 to normalize. The cut-offs used to identify differentially expressed
genes were an adjusted p-value<0.0001 and |log2 fold change| > 1.
Quantitative RT-PCR
Total RNA was isolated using RNAeasy Mini Kit (Qiagen) and cDNA was prepared using an iScript
cDNA synthesis kit (BioRad). qPCR was carried out using a CFX384 Real-Time PCR Detection Sys-
tem. Gene expression was normalized to GAPDH using the DD CT method. Primer sets used are
available on request.
Entrez Gene Symbol     Unique Sequences    Tandome_Detections
       IER5           12                   0
       PPP2R2A           8                   0
       PPP2R1A               8                    0
       PPP2CA           3                   0
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Figure 6. IER5 binds to B55a. (A) Polypeptides identified by mass spectroscopy in immunoprecipitates prepared from I5 cells expressing tandem-
tagged IER5. (B) Cartoon showing the structure of tandem-tagged IER5 polypeptides. FH, FLAG-HA tag. (C) Western blot analysis of
immunoprecipitates prepared from I5 cells expressing the indicated forms of tagged IER5. WO, washout. (D) Western blot analysis of
immunoprecipitates prepared from SC2 cells expressing FLAG-tagged B55a. (E) Western blot showing that IER5 binds His-Sumo-tagged B55a
immobilized on beads. The upper two panels were stained for IER5, while the lower two panels were stained for SUMO. (F) Microscale thermophoresis
showing saturable binding of IER5 to His-Sumo-tagged B55a.
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Figure 7. PPP2R2A is epistatic to IER5. (A) Western blot showing IER5 and B55a protein levels in single (KO) and double (DKO) PPP2R2A and IER5
knockout clones in the presence of GSI (-) and 4 hr after GSI washout (+). (B) PPP2R2A knockout enhances Notch-dependent expression of KRT1. RT-
PCR analysis of KRT1 expression in SC2 cells transduced with an empty retrovirus (SC2/EV); PPP2R2A knockout cells (B55 KO) transduced with empty
retrovirus (B55KO/EV); and PPP2R2A knockout cells transduced with B55a-expressing retrovirus (B55KO/B55AB). WO = GSI washout. *, p<0.05; **,
Figure 7 continued on next page
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In situ hybridization
In situ hybridization (ISH) reagents were from Advanced Cell Diagnostics. Deidentified normal human
skin was obtained from the paraffin archives of the Department of Pathology at Brigham and Wom-
en’s Hospital under institutional review board protocol #2014P001256. Briefly, 4m sections of skin
were deparaffinized, processed using RNAscope 2.5 Universal Pretreatment Reagent, and hybrid-
ized to probes specific for human IER5, human PPIB (peptidylprolyl isomerase B), or bacterial DapB
in a HybEZ II oven. ISH signal was developed using the RNAscope 2.5 HD Assay.
Immunostaining of cells and organotypic rafts
Antibody sources and antibody dilutions are provided in the Key Resource Table. For indirect immu-
nofluorescence microscopy, cells grown on chamber microscope slides were fixed in 4% paraformal-
dehyde and treated with immunofluorescence blocking buffer (catalog #12411, Cell Signaling
Technology). Staining with primary antibodies against involucrin or plakophilin-1 in antibody dilution
buffer (catalog #12378, Cell Signaling Technology) was developed by incubation with Alexa Fluor-
conjugated secondary antibodies (Cell Signaling Technology, 1:1000). After counterstaining with
DAPI (BioLegend, catalog #422801), slides were coverslipped with ProLong Gold Antifade Reagent
(Cell Signaling Technology, catalog #9071) and imaged on a Nikon 80i immunofluorescence micro-
scope. Rafts were fixed in 4% buffered formalin for 24 hr, processed, and paraffin-embedded. Sec-
tions (4m) were placed on Superfrost Plus slides and baked at 60˚C for 1 hr. Immunohistochemical
staining was performed on a Leica Bond III instrument using the following primary antibodies and
Leica antigen retrieval conditions: involucrin, retrieval H1 (30 min); plakophilin1, retrieval H1 (30
min); keratin1, H1 retrieval (30 min); keratin5, retrieval H2 (20 min); keratin14, retrieval H2 (20 min);
BCL6, retrieval H2 (20 min); p63, retrieval H2 (40 min); filaggrin, retrieval H1 (30 min); loricrin,
retrieval H1 (30 min); Ki67, retrieval H2 (20 min); or ICN1, retrieval H2 (40 min). Diaminobenzidine
(DAB) staining was developed using the Bond Polymer Refine Detection Kit (Leica). Slides were
counterstained with hematoxylin. Digital micrographs were captured with an Olympus BX40 micro-
scope and Olympus cellSens Entry software.
Reporter gene assays
Luciferase reporter genes containing IER5-associated enhancers were assembled in pGL3-TATA
(Wang et al., 2014). Mutatagenesis was with the QuickChange II kit (Agilent Technologies). Lucifer-
ase assays were performed using Dual Luciferase Assay Kit (Promega) as described (Malecki et al.,
2006) using lysates from cultured cells that were co-transfected with firefly luciferase and internal
control Renilla luciferase plasmids using Lipofactamine 2000 (Thermo Fisher Scientific).
Western blotting and immunoprecipitation
Antibody sources and dilutions are provided in the Key Resource Table. Whole cell lysates were pre-
pared as described (Malecki et al., 2006). Protein concentration was measured by Bradford assay
(Bio-Rad) prior to SDS-PAGE. Western blots staining was developed with Super Signal West Pico
Chemiluminescent Substrate (Thermo Scientific). To prepare immunoprecipitates, cells were lysed in
50 mM Tris, pH 7.4, containing 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitors
(Sigma). Lysates were incubated overnight at 4˚C with 20 ml anti-FLAG M2 magnetic beads (Sigma).
After extensive washing, bound proteins were eluted with FLAG peptide (Sigma) and analyzed on
western blots as above.
Figure 7 continued
p<0.005 (two-tailed student t test). (C) Immunohistochemical (IHC) staining for involucrin of SC2 control, B55KO, and B55KO/B55AB cells in raft cultures
in GSI-free medium. (D) B55a knockout negates the requirement for IER5 for Notch-dependent upregulation of KRT1. Results are shown for SC2 control
cells (SC2/EV); an IER5 knockout clone; a PPP2R2A knockout clone (B55KO); and three IER5/PPP2R2A double knockout (DKO) clones. Cells were
maintained in GSI or harvested 72 hr following GSI washout (WO). KRT1 transcript abundance was measured in biological replicates prepared in
triplicate by RT-PCR and normalized against GAPDH. Error bars represent standard errors of the mean. *, p<0.05; **, p<0.005; ***, p<0.0005; ****,
p<0.00005 (all two-tailed student t test).
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Affinity purification of IER5 complexes and mass spectrometry
Mass spectroscopy was performed on tandem affinity purified IER5 complexes prepared from IE5
knockout (I5) cells expressing tandem tagged IER5 48 hr after GSI washout. Lysis of cells and subse-
quent tandem purification were as described (Adelmant et al., 2019). Tryptic peptides were ana-
lyzed by electrospray mass spectrometry (QExactive HF mass spectrometer, Thermo Fisher; Digital
PicoView electrospray source platform, New Objective). Spectra were recalibrated using the back-
ground ion (Si(CH3)2O)six at m/z 445.12 + / - 0.03 and converted to a Mascot generic file format (.
mgf) using multiplierz scripts (Askenazi et al., 2009; Parikh et al., 2009). Spectra were searched
using Mascot (v2.6) against three databases: (i) human protein sequences (downloaded from
RefSeq); (ii) common lab contaminants; and (iii) a decoy database generated by reversing the
sequences from these two databases. Spectra matching peptides from the reverse database were
used to calculate a global FDR and were discarded, as were matches to the forward database with
FDR > 1.0% and those present in >1% of 108 negative tandem affinity purification controls (Rozen-
blatt-Rosen et al., 2012).
Recombinant protein expression and purification
A cDNA encoding B55a with 6xHis-SUMO N-terminal tag was cloned into the baculovirus transfer
vector pVL1392. High-titer baculovirus supernatants were used to infect insect Sf9 cells grown at a
density of 4.0  106 cell/mL. After 72 hr of incubation at 27˚C, conditioned media was isolated by
centrifugation, supplemented with 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 5 mM
CaCl2, 1 mM NiCl2, and 0.01 mM ZnCl2, re-centrifuged to remove residual debris, and applied to a
Ni-NTA column. After washing with 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl and 5
mMCaCl2, B55a was eluted in the same buffer supplemented with 500 mM imidazole. This eluate
was concentrated with a centrifugal filter and then subject to S200 size exclusion chromatography in
20 mM Na cacodylate, pH 6.0, containing 150 mM NaCl, and 5 mM CaCl2. Fractions containing
B55a were further purified by ion exchange chromatography on a MonoQ column in 20 mM Na
cacodylate, pH 6.0, using a linear NaCl gradient. The purified protein was buffer-exchanged into 20
mM HEPES buffer, pH 7.5, containing 150 mM NaCl, prior to flash freezing and storage at  80˚C. A
cDNA encoding IER5 with a N-terminal 6xHis-SUMO tag was cloned into pTD6 and used to trans-
form Rosetta E. coli cells. Expression of IER5 was induced at 37˚C for 4 hr with IPTG induction fol-
lowed by inclusion body preparation. Lysates were centrifuged at 4˚C for 20 min at 30,000 x g and
pellets were resuspended in 10 mL wash buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, containing
1% Triton X-100 and 1M urea) per gram cell weight, and incubated at 23˚C for 5 min. Following mul-
tiple washes, inclusion bodies were resuspended in extraction buffer (50 mM Tris-HCl, pH 7.5, 8M
urea, 1 mM b-mercaptoethanol, 1 mM PMSF) and incubated at room temperature for 1 hr. The solu-
bilized proteins were then dialyzed overnight against a 100-fold volume of wash buffer and cleared
by centrifugation. 6x-his-IER5 was then concentrated on Ni-NTA beads, eluted with 500 mM imidaz-
ole, cleaved using SUMO protease (SUMOpro, Lifesensors), and passed back over Ni-NTA beads.
Untagged IER5 was then purified by chromatography on S200 and MonoQ columns as described for
B55a.
IER5/B55a-binding assays
For bead pulldown assays, 5 mM purified His-SUMO-B55a bait was bound to 100 ul Ni-NTA beads,
which were mixed with different concentrations of purified IER5 in 20 mM HEPES buffer, pH 7.5,
containing 150 mM NaCl for 1 hr. Control binding assays were conducted with purified His-SUMO
bound to Ni-NTA beads. Following extensive washing, proteins were eluted by boiling in SDS-PAGE
loading buffer and analyzed on SDS-PAGE gels followed by western blotting. Microscale thermo-
phoresis assays were performed on a NanoTemper Monolith NT.115 instrument with blue/red filters
(NanoTemper Technologies GmbH, Munich, Germany). Samples were prepared in 20 mM Tris-HCl,
pH 7.5, containing 150 mM NaCl, 1 mM b-mercaptoethanol, 1% glycerol, 0.05% Tween-20, and
loaded into premium treated capillaries. Measurements were performed at 22˚ C using 20% MST
power with laser off/on times of 5 s and 30 s, respectively. His-SUMO-B55a target labeled with red
fluorescent detector as per the NanoTemper His-labeling kit was used at a concentration of 10 nM
and mixed with 16 serial dilutions of purified IER5 ligand from 5 mM to 0.000153 mM. All experiments
were repeated three times. Data analyses were performed using NanoTemper analysis software.
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CRISPR/Cas9 targeting and site directed mutagenesis
Guide RNAs (gRNAs) were designed using software available at http://crispr.mit.edu. To score the
effects of gene editing in bulk cell populations, gRNAs were cloned into pL-CRISPR.SFFV.GFP and
transiently transfected using Lipofactamine 2000 (Thermo Fisher Scientific). Cells sorted for GFP
expression 48 hr post-transfection were used in downstream analyses. To create double knockout
cells, single-cell clones bearing single-gene knockouts were transduced with pL-CRISPR.SFFV.GFP
bearing gRNA. Lentivirus was packaged by co-transfection with psPAX2 and pMD2.G. To create
deletions, pairs of gRNAs flanking genomic regions of interest were cloned into lentiCRISPRv2 neo
and lentiCRISPRv2 hygro, or into pL-CRISPR.SFFV.GFP and pL-CRISPR.SFFV.RFP. Double deletants
were isolated sequentially by selection for RFP/GFP double positivity and G418/hygromycin resis-
tance. The sequences of gRNAs used are available on request.
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